个人中心 - 老虎社区

栗羽

IP属地：未知

帖子 · 4帖子 · 4
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 栗羽栗羽
  ·2021-10-22
  $Vaxart, Inc(VXRT)$What happen to you?
  442 评论
  1
  分享
  举报
- 栗羽栗羽
  ·2021-06-25
  Long play
  3 Revolutionary Stocks That Can Make You Rich
  Artificial intelligence and machine learning are competitive advantages they've had from the start.
  3 Revolutionary Stocks That Can Make You Rich
  831 评论
  点赞
  分享
  举报
- 栗羽栗羽
  ·2021-06-21
  [Miser]
  Stock market's most popular trade faces 'perfect storm'
  Wall Street’s favorite trade of the year is facing a "perfect storm" as theFederal Reserveprepares t
  Stock market's most popular trade faces 'perfect storm'
  685 评论
  1
  分享
  举报
- 栗羽栗羽
  ·2021-06-16
  Nice
  Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner
  Novavax Inc COVID-19 vaccine, marketed as "Covovax," could see a launch in India as early as Septemb
  Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner
  641 评论
  1
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3577247183854045","uuid":"3577247183854045","gmtCreate":1614266223301,"gmtModify":1623837501844,"name":"栗羽","pinyin":"lyliyu","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/ed8fb10b2d0fa5e8acbe48641819ef92","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.99%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":851274272,"gmtCreate":1634912635543,"gmtModify":1634912635617,"author":{"id":"3577247183854045","authorId":"3577247183854045","name":"栗羽","avatar":"https://static.tigerbbs.com/ed8fb10b2d0fa5e8acbe48641819ef92","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577247183854045","idStr":"3577247183854045"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VXRT\">$Vaxart, Inc(VXRT)$</a>What happen to you?","listText":"<a href=\"https://laohu8.com/S/VXRT\">$Vaxart, Inc(VXRT)$</a>What happen to you?","text":"$Vaxart, Inc(VXRT)$What happen to you?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851274272","isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":126831302,"gmtCreate":1624550504906,"gmtModify":1634004461839,"author":{"id":"3577247183854045","authorId":"3577247183854045","name":"栗羽","avatar":"https://static.tigerbbs.com/ed8fb10b2d0fa5e8acbe48641819ef92","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577247183854045","idStr":"3577247183854045"},"themes":[],"htmlText":"Long play&nbsp;","listText":"Long play&nbsp;","text":"Long play","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126831302","repostId":"2145046329","repostType":4,"repost":{"id":"2145046329","kind":"highlight","pubTimestamp":1624540260,"share":"https://ttm.financial/m/news/2145046329?lang=&edition=full","pubTime":"2021-06-24 21:11","market":"us","language":"en","title":"3 Revolutionary Stocks That Can Make You Rich","url":"https://stock-news.laohu8.com/highlight/detail?id=2145046329","media":"Motley Fool","summary":"Artificial intelligence and machine learning are competitive advantages they've had from the start.","content":"<p>Artificial intelligence (AI) is popping up everywhere. That's because it's a competitive advantage for companies that harness its power. Like computers, the internet, and the cloud before it, many companies claim to use it. But the truly innovative companies have built their businesses on AI from the ground up. And they are quickly outpacing competitors.</p>\n<p>Three companies that are following this path to carve out entirely new approaches to old problems are <b>Moderna</b> (NASDAQ:MRNA), <b>Upstart</b> <b>Holdings</b> (NASDAQ:UPST), and <b>The</b> <b>Trade</b> <b>Desk</b> (NASDAQ:TTD). Although the stock prices of all have risen sharply, market-beating gains should still lie ahead.</p>\n<p><img src=\"https://static.tigerbbs.com/50a91906606dc42d1b6a9db535011f65\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>1. Moderna</h3>\n<p>Moderna entered the public's consciousness when it became an early leader in the race to develop a vaccine for COVID-19. The company took just 42 days from getting the genome of the virus to shipping a drug candidate for human testing. That speed was by design. CEO Stephane Bancel set out to make Moderna \"the first truly digital biotech company.\"</p>\n<p>It has invested more than $100 million in digitization, automation, and data science -- AI and machine learning (ML) -- since its inception, and plans to double down over the next five years. It uses machine learning to optimize manufacturing processes and increase the quality of the mRNA it produces. This lowers the cost and increases how fast it can design, develop, and select new therapies for trial.</p>\n<p>The Moderna COVID-19 vaccine is just the first treatment to bear fruit for patients and shareholders. The stock is up 965% since the beginning of 2020 and management expects it to generate at least $19.2 billion in revenue this year. The company isn't stopping there. It has 25 candidates in its pipeline, including some for solid tumors and personalized cancer vaccines. If its COVID-19 vaccine is any indication, Moderna could be on the cusp of becoming the leader in a new era of medicine. Its ability to employ AI and ML is accelerating the change.</p>\n<h3>2. Upstart Holdings</h3>\n<p>Traditional lending decisions are typically only based on a few variables and rarely quantify risk. That leaves many consumers paying more for loans than they should or unable to obtain them at all. That's also bad for borrowers, who need to compete in a highly fragmented industry.</p>\n<p>Upstart Holdings has created a better way to assess risk and improve credit decisions. Its decision engine isn't a manual process that has been digitized. Instead, its machine learning models -- trained on more than 1,000 variables and 10.5 million repayment events -- augment or replace the traditional process. The company is also using ML to reduce the friction borrowers experience in the verification process. In all, it has helped the company grow loan volume by a factor of 20 over the past four years.</p>\n<p>The company mostly counts regional banks and credit unions as its customers. They're adopting the approach as a way to compete with larger financial institutions. The AI-enhanced lending has helped them increase loan volume while decreasing the average interest rate borrowers are paying. That's true for traditionally underserved demographics as well. It's a win-win, and the Consumer Financial Protection Bureau (CFPB) agrees. Using the agency's criteria, Upstart's AI model approved 27% more loan applications at a 16% lower average interest rate. The company is in year two of a \"no action letter\" from the CFPB -- a stamp of approval.</p>\n<p>Lenders have signed up in droves. In the first quarter of 2021, revenue was up 90%. The company is expecting the top line to grow 157% for the full fiscal year. Some of the growth is attributable to a recent acquisition that gives it access to the $1.3 trillion auto lending industry. Until now, it was focused on personal loans. Upstart is methodically making its way through the consumer lending market using machine learning to benefit both lenders and borrowers. It's in the early innings of a disruption that could go on for decades. The numbers show it's gaining steam.</p>\n<h3>3. The Trade Desk</h3>\n<p>Ever since smartphones became ubiquitous, how people enjoy content has changed. The media landscape has become more digital, leading to audiences spread out across websites, streaming apps, and the like. It's led to advertisers having to work harder to reach the same large audiences they used to. The Trade Desk is helping them work smarter.</p>\n<p>The company's self-service platform lets advertisers create and manage their ad campaigns in a way that optimizes spending across multiple channels and formats. Since the company only works with ad buyers, they are viewed as a trusted enabler -- not a disruptor -- adding value to the industry. On the company's platform, advertisers can use their own data, as well as build their own applications. Of course, The Trade Desk offers its own services, including machine learning models that optimize campaigns. The company has an incredible amount of data, and its models improve with every ad. It's a formula that since 2016 has seen revenue and the stock climb 340% and 2,000%, respectively.</p>\n<p>The stock is currently 33% off of its highs after announcements from <b>Apple</b> and <b>Google</b> about eliminating the use of cookies -- the code on websites that identifies users and helps track them across the internet. Those only account for about 20% of data-driven ads but the Trade Desk has an answer. It created Unified ID (UID) 2.0 as an anonymized alternative and it has a lot of momentum. It made it open source, essentially donating it to the industry.</p>\n<p>Analysts are still asking if consumers will opt in to the system. According to CEO Jeff Green, they will. And he believes the changes will ultimately prove positive for the company. With more than a decade adapting to changes in the industry, he is in the best position to know. For that reason, any sell-off in the stock is likely a buying opportunity for investors with a long-term horizon.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Revolutionary Stocks That Can Make You Rich</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Revolutionary Stocks That Can Make You Rich\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 21:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/24/3-revolutionary-stocks-that-can-make-you-rich/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artificial intelligence (AI) is popping up everywhere. That's because it's a competitive advantage for companies that harness its power. Like computers, the internet, and the cloud before it, many ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/24/3-revolutionary-stocks-that-can-make-you-rich/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","UPST":"Upstart Holdings, Inc.","TTD":"Trade Desk Inc."},"source_url":"https://www.fool.com/investing/2021/06/24/3-revolutionary-stocks-that-can-make-you-rich/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145046329","content_text":"Artificial intelligence (AI) is popping up everywhere. That's because it's a competitive advantage for companies that harness its power. Like computers, the internet, and the cloud before it, many companies claim to use it. But the truly innovative companies have built their businesses on AI from the ground up. And they are quickly outpacing competitors.\nThree companies that are following this path to carve out entirely new approaches to old problems are Moderna (NASDAQ:MRNA), Upstart Holdings (NASDAQ:UPST), and The Trade Desk (NASDAQ:TTD). Although the stock prices of all have risen sharply, market-beating gains should still lie ahead.\n\nImage source: Getty Images.\n1. Moderna\nModerna entered the public's consciousness when it became an early leader in the race to develop a vaccine for COVID-19. The company took just 42 days from getting the genome of the virus to shipping a drug candidate for human testing. That speed was by design. CEO Stephane Bancel set out to make Moderna \"the first truly digital biotech company.\"\nIt has invested more than $100 million in digitization, automation, and data science -- AI and machine learning (ML) -- since its inception, and plans to double down over the next five years. It uses machine learning to optimize manufacturing processes and increase the quality of the mRNA it produces. This lowers the cost and increases how fast it can design, develop, and select new therapies for trial.\nThe Moderna COVID-19 vaccine is just the first treatment to bear fruit for patients and shareholders. The stock is up 965% since the beginning of 2020 and management expects it to generate at least $19.2 billion in revenue this year. The company isn't stopping there. It has 25 candidates in its pipeline, including some for solid tumors and personalized cancer vaccines. If its COVID-19 vaccine is any indication, Moderna could be on the cusp of becoming the leader in a new era of medicine. Its ability to employ AI and ML is accelerating the change.\n2. Upstart Holdings\nTraditional lending decisions are typically only based on a few variables and rarely quantify risk. That leaves many consumers paying more for loans than they should or unable to obtain them at all. That's also bad for borrowers, who need to compete in a highly fragmented industry.\nUpstart Holdings has created a better way to assess risk and improve credit decisions. Its decision engine isn't a manual process that has been digitized. Instead, its machine learning models -- trained on more than 1,000 variables and 10.5 million repayment events -- augment or replace the traditional process. The company is also using ML to reduce the friction borrowers experience in the verification process. In all, it has helped the company grow loan volume by a factor of 20 over the past four years.\nThe company mostly counts regional banks and credit unions as its customers. They're adopting the approach as a way to compete with larger financial institutions. The AI-enhanced lending has helped them increase loan volume while decreasing the average interest rate borrowers are paying. That's true for traditionally underserved demographics as well. It's a win-win, and the Consumer Financial Protection Bureau (CFPB) agrees. Using the agency's criteria, Upstart's AI model approved 27% more loan applications at a 16% lower average interest rate. The company is in year two of a \"no action letter\" from the CFPB -- a stamp of approval.\nLenders have signed up in droves. In the first quarter of 2021, revenue was up 90%. The company is expecting the top line to grow 157% for the full fiscal year. Some of the growth is attributable to a recent acquisition that gives it access to the $1.3 trillion auto lending industry. Until now, it was focused on personal loans. Upstart is methodically making its way through the consumer lending market using machine learning to benefit both lenders and borrowers. It's in the early innings of a disruption that could go on for decades. The numbers show it's gaining steam.\n3. The Trade Desk\nEver since smartphones became ubiquitous, how people enjoy content has changed. The media landscape has become more digital, leading to audiences spread out across websites, streaming apps, and the like. It's led to advertisers having to work harder to reach the same large audiences they used to. The Trade Desk is helping them work smarter.\nThe company's self-service platform lets advertisers create and manage their ad campaigns in a way that optimizes spending across multiple channels and formats. Since the company only works with ad buyers, they are viewed as a trusted enabler -- not a disruptor -- adding value to the industry. On the company's platform, advertisers can use their own data, as well as build their own applications. Of course, The Trade Desk offers its own services, including machine learning models that optimize campaigns. The company has an incredible amount of data, and its models improve with every ad. It's a formula that since 2016 has seen revenue and the stock climb 340% and 2,000%, respectively.\nThe stock is currently 33% off of its highs after announcements from Apple and Google about eliminating the use of cookies -- the code on websites that identifies users and helps track them across the internet. Those only account for about 20% of data-driven ads but the Trade Desk has an answer. It created Unified ID (UID) 2.0 as an anonymized alternative and it has a lot of momentum. It made it open source, essentially donating it to the industry.\nAnalysts are still asking if consumers will opt in to the system. According to CEO Jeff Green, they will. And he believes the changes will ultimately prove positive for the company. With more than a decade adapting to changes in the industry, he is in the best position to know. For that reason, any sell-off in the stock is likely a buying opportunity for investors with a long-term horizon.","news_type":1,"symbols_score_info":{"MRNA":0.9,"TTD":0.9,"UPST":0.9}},"isVote":1,"tweetType":1,"viewCount":831,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167195729,"gmtCreate":1624250877461,"gmtModify":1634008861547,"author":{"id":"3577247183854045","authorId":"3577247183854045","name":"栗羽","avatar":"https://static.tigerbbs.com/ed8fb10b2d0fa5e8acbe48641819ef92","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577247183854045","idStr":"3577247183854045"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167195729","repostId":"1134946846","repostType":4,"repost":{"id":"1134946846","kind":"news","pubTimestamp":1624244425,"share":"https://ttm.financial/m/news/1134946846?lang=&edition=full","pubTime":"2021-06-21 11:00","market":"us","language":"en","title":"Stock market's most popular trade faces 'perfect storm'","url":"https://stock-news.laohu8.com/highlight/detail?id=1134946846","media":"FoxBusiness","summary":"Wall Street’s favorite trade of the year is facing a \"perfect storm\" as theFederal Reserveprepares t","content":"<p>Wall Street’s favorite trade of the year is facing a \"perfect storm\" as theFederal Reserveprepares to exit the emergency measures put in place during the pandemic, according to Bank of America.</p>\n<p>The Fed’s decision to end the easy money era of the pandemic sent shockwaves through the market and put the Dow Jones Industrial Average on track for its worst week since January.</p>\n<p>Cyclical stocks on Thursday, the day after the announcement, suffered their worst day in over a year when compared to defensive stocks as investors feared the central bank’s tapering could derail the economy. Cyclicals include sectors like industrials, energy and financials, whose performance is tied to the whims of the economy.</p>\n<p>A \"cyclical correction is now underway,\" wrote a team led by Michael Hartnett, chief investment strategist at Bank of America.</p>\n<p>He noted this week’s hawkish shift by the Fed is \"bad news\" and adds to the troubles that were presented by excess positioning, China tightening and fading hopes of additional fiscal stimulus in the U.S.</p>\n<p>The Fed on Wednesday held its benchmark interest rate near zero and maintained its bond-buying program at a pace of $120 billion per month, but moved up the forecast for its first rate hike to 2023 from 2024. More members, but not a majority, said the first rate hike could occur in 2022. The central bank also teased an end to its asset purchase program, but did not give any specifics as to when the tapering might begin.</p>\n<p>The Fed last year cut interest rates to near zero and pledged to buy an unlimited amount of assets to support the U.S. economy through its sharpest economic slowdown of the post-World War II era.</p>\n<p>The yield on the 10-year bond note fell to 1.45% on Friday in response to the Fed’s tightening plans. It hit a high of 1.75% on March 31.</p>\n<p>David Rosenberg, chief economist and strategist at Toronto-based Rosenberg Research says that adjusted for interest rates, the S&amp;P 500 is 20% above its intrinsic value.</p>\n<p>He believes investors would be foolish to ignore the signal that real rates, or those adjusted for inflation, are sending to the stock market.</p>\n<p>\"Overweighting&nbsp;defensive sectors and secular growth segments that tend to benefit&nbsp;by a sharp slowing in GDP growth, is a sound strategy,\" he wrote. \"At the same&nbsp;time, if the message from real rates proves&nbsp;prescient, investors will&nbsp;be well advised to trim their cyclical exposures.\"</p>","source":"lsy1610518597439","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock market's most popular trade faces 'perfect storm'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock market's most popular trade faces 'perfect storm'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.foxbusiness.com/markets/stock-market-most-popular-trade-being-turned-upside-down><strong>FoxBusiness</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street’s favorite trade of the year is facing a \"perfect storm\" as theFederal Reserveprepares to exit the emergency measures put in place during the pandemic, according to Bank of America.\nThe ...</p>\n\n<a href=\"https://www.foxbusiness.com/markets/stock-market-most-popular-trade-being-turned-upside-down\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://www.foxbusiness.com/markets/stock-market-most-popular-trade-being-turned-upside-down","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134946846","content_text":"Wall Street’s favorite trade of the year is facing a \"perfect storm\" as theFederal Reserveprepares to exit the emergency measures put in place during the pandemic, according to Bank of America.\nThe Fed’s decision to end the easy money era of the pandemic sent shockwaves through the market and put the Dow Jones Industrial Average on track for its worst week since January.\nCyclical stocks on Thursday, the day after the announcement, suffered their worst day in over a year when compared to defensive stocks as investors feared the central bank’s tapering could derail the economy. Cyclicals include sectors like industrials, energy and financials, whose performance is tied to the whims of the economy.\nA \"cyclical correction is now underway,\" wrote a team led by Michael Hartnett, chief investment strategist at Bank of America.\nHe noted this week’s hawkish shift by the Fed is \"bad news\" and adds to the troubles that were presented by excess positioning, China tightening and fading hopes of additional fiscal stimulus in the U.S.\nThe Fed on Wednesday held its benchmark interest rate near zero and maintained its bond-buying program at a pace of $120 billion per month, but moved up the forecast for its first rate hike to 2023 from 2024. More members, but not a majority, said the first rate hike could occur in 2022. The central bank also teased an end to its asset purchase program, but did not give any specifics as to when the tapering might begin.\nThe Fed last year cut interest rates to near zero and pledged to buy an unlimited amount of assets to support the U.S. economy through its sharpest economic slowdown of the post-World War II era.\nThe yield on the 10-year bond note fell to 1.45% on Friday in response to the Fed’s tightening plans. It hit a high of 1.75% on March 31.\nDavid Rosenberg, chief economist and strategist at Toronto-based Rosenberg Research says that adjusted for interest rates, the S&P 500 is 20% above its intrinsic value.\nHe believes investors would be foolish to ignore the signal that real rates, or those adjusted for inflation, are sending to the stock market.\n\"Overweighting defensive sectors and secular growth segments that tend to benefit by a sharp slowing in GDP growth, is a sound strategy,\" he wrote. \"At the same time, if the message from real rates proves prescient, investors will be well advised to trim their cyclical exposures.\"","news_type":1,"symbols_score_info":{".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169644409,"gmtCreate":1623835063701,"gmtModify":1634027368964,"author":{"id":"3577247183854045","authorId":"3577247183854045","name":"栗羽","avatar":"https://static.tigerbbs.com/ed8fb10b2d0fa5e8acbe48641819ef92","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577247183854045","idStr":"3577247183854045"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169644409","repostId":"1107989851","repostType":4,"repost":{"id":"1107989851","kind":"news","pubTimestamp":1623833866,"share":"https://ttm.financial/m/news/1107989851?lang=&edition=full","pubTime":"2021-06-16 16:57","market":"us","language":"en","title":"Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=1107989851","media":"benzinga","summary":"Novavax Inc COVID-19 vaccine, marketed as \"Covovax,\" could see a launch in India as early as Septemb","content":"<p><b>Novavax Inc</b>&nbsp;COVID-19 vaccine, marketed as&nbsp;\"Covovax,\" could see a launch&nbsp;in India as early as September, Moneycontrol&nbsp;reportedon Wednesday.</p>\n<p><b>What Happened:</b>Covovax trials have reached an advanced stage of completion in India following which the U.S.-based vaccine maker’s India partner Serum Institute of India (SII) will launch the vaccine, the report said citing Adar Poonawalla, chief executive officer at SII.</p>\n<p>Novavax’s coronavirus vaccine trial in India is likely to conclude by November, however, the pharma company can apply for a license for the vaccine on the basis of global data, Poonawalla noted.</p>\n<p>The U.S.-based biotechnology firm had earlier this week said that its COVID-19vaccine demonstratedover 90.4% efficacy. The study enrolled 29,960 participants.</p>\n<p>Novavax is also planning to start clinical trials of Covovax for children in July, the report added. Novavax and SII had in September partnered for the former's&nbsp;COVID-19 vaccine candidate NVX-CoV2373.</p>\n<p><b>AstraZeneca Inc's</b>&nbsp;vaccine, marketed as \"Covishied\" in the country, is currently being widely administered as part of the vaccination drive in India, alongside locally produced Covaxin and Russia's Sputnik V.</p>\n<p><b>Ocugen Inc.</b>&nbsp;is the U.S. partner for Covaxin.</p>\n<p><b>Price Action:</b>Novavax shares closed 9.94% at $187.07 on Tuesday and were down 0.68% in extended hours.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax COVID-19 Vaccine Could Become Available In India By September, Says Partner\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 16:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/06/21581892/novavax-covid-19-vaccine-could-become-available-in-india-by-september-says-partner><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax Inc COVID-19 vaccine, marketed as \"Covovax,\" could see a launch in India as early as September, Moneycontrol reportedon Wednesday.\nWhat Happened:Covovax trials have reached an advanced stage ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/06/21581892/novavax-covid-19-vaccine-could-become-available-in-india-by-september-says-partner\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.benzinga.com/general/biotech/21/06/21581892/novavax-covid-19-vaccine-could-become-available-in-india-by-september-says-partner","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107989851","content_text":"Novavax Inc COVID-19 vaccine, marketed as \"Covovax,\" could see a launch in India as early as September, Moneycontrol reportedon Wednesday.\nWhat Happened:Covovax trials have reached an advanced stage of completion in India following which the U.S.-based vaccine maker’s India partner Serum Institute of India (SII) will launch the vaccine, the report said citing Adar Poonawalla, chief executive officer at SII.\nNovavax’s coronavirus vaccine trial in India is likely to conclude by November, however, the pharma company can apply for a license for the vaccine on the basis of global data, Poonawalla noted.\nThe U.S.-based biotechnology firm had earlier this week said that its COVID-19vaccine demonstratedover 90.4% efficacy. The study enrolled 29,960 participants.\nNovavax is also planning to start clinical trials of Covovax for children in July, the report added. Novavax and SII had in September partnered for the former's COVID-19 vaccine candidate NVX-CoV2373.\nAstraZeneca Inc's vaccine, marketed as \"Covishied\" in the country, is currently being widely administered as part of the vaccination drive in India, alongside locally produced Covaxin and Russia's Sputnik V.\nOcugen Inc. is the U.S. partner for Covaxin.\nPrice Action:Novavax shares closed 9.94% at $187.07 on Tuesday and were down 0.68% in extended hours.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}